Menu
GeneBe

7-93297177-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_017667.4(VPS50):c.1295G>C(p.Ser432Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

VPS50
NM_017667.4 missense

Scores

3
4
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 9.94
Variant links:
Genes affected
VPS50 (HGNC:25956): (VPS50 subunit of EARP/GARPII complex) Enables SNARE binding activity. Acts upstream of or within endocytic recycling. Located in recycling endosome. Part of EARP complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.39030528).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
VPS50NM_017667.4 linkuse as main transcriptc.1295G>C p.Ser432Thr missense_variant 16/28 ENST00000305866.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
VPS50ENST00000305866.10 linkuse as main transcriptc.1295G>C p.Ser432Thr missense_variant 16/281 NM_017667.4 P1Q96JG6-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 01, 2022The c.1295G>C (p.S432T) alteration is located in exon 16 (coding exon 16) of the VPS50 gene. This alteration results from a G to C substitution at nucleotide position 1295, causing the serine (S) at amino acid position 432 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Uncertain
0.076
D
BayesDel_noAF
Benign
-0.13
Cadd
Pathogenic
27
Dann
Uncertain
0.99
DEOGEN2
Benign
0.032
T;.
Eigen
Pathogenic
0.78
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.39
T;T
MetaSVM
Benign
-0.61
T
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.21
Sift
Benign
0.12
T;T
Sift4G
Benign
0.14
T;T
Polyphen
0.92
P;.
Vest4
0.59
MutPred
0.26
Loss of disorder (P = 0.0568);.;
MVP
0.19
MPC
0.81
ClinPred
0.96
D
GERP RS
5.1
Varity_R
0.33
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr7-92926489; API